Gradient Investments LLC Has $5.33 Million Stock Holdings in Humana Inc. $HUM

Gradient Investments LLC trimmed its position in shares of Humana Inc. (NYSE:HUM) by 31.3% during the 2nd quarter, HoldingsChannel reports. The fund owned 13,408 shares of the insurance provider’s stock after selling 6,112 shares during the quarter. Gradient Investments LLC’s holdings in Humana were worth $5,326,000 as of its most recent filing with the Securities & Exchange Commission.

Other large investors have also recently added to or reduced their stakes in the company. Montag A & Associates Inc. lifted its position in shares of Humana by 1,880.0% in the 4th quarter. Montag A & Associates Inc. now owns 99 shares of the insurance provider’s stock worth $25,000 after acquiring an additional 94 shares during the period. Fideuram Asset Management Ireland dac bought a new stake in shares of Humana during the fourth quarter valued at approximately $27,000. Reflection Asset Management bought a new stake in shares of Humana during the fourth quarter valued at approximately $29,000. Global Assets Advisory LLC acquired a new position in shares of Humana in the first quarter valued at $38,000. Finally, Larson Financial Group LLC lifted its position in Humana by 114.1% in the third quarter. Larson Financial Group LLC now owns 152 shares of the insurance provider’s stock worth $40,000 after purchasing an additional 81 shares during the period. Institutional investors and hedge funds own 92.38% of the company’s stock.

Humana Stock Performance

NYSE:HUM opened at $384.44 on Friday. The stock has a market capitalization of $46.16 billion, a P/E ratio of 36.37, a price-to-earnings-growth ratio of 2.20 and a beta of 0.72. The company has a current ratio of 1.74, a quick ratio of 1.74 and a debt-to-equity ratio of 0.62. Humana Inc. has a 1 year low of $163.11 and a 1 year high of $428.88. The firm has a 50 day moving average of $377.18 and a 200-day moving average of $271.65.

Humana (NYSE:HUM) last released its quarterly earnings results on Wednesday, July 29th. The insurance provider reported $7.61 EPS for the quarter, topping analysts’ consensus estimates of $7.27 by $0.34. Humana had a return on equity of 11.20% and a net margin of 0.88%.The business had revenue of $40.89 billion for the quarter, compared to analyst estimates of $40.58 billion. During the same period in the prior year, the company earned $6.27 EPS. Humana’s revenue for the quarter was up 26.2% on a year-over-year basis. As a group, sell-side analysts anticipate that Humana Inc. will post 9.08 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of research firms have weighed in on HUM. Weiss Ratings downgraded shares of Humana from a “hold (c)” rating to a “hold (c-)” rating in a research note on Thursday, July 30th. The Goldman Sachs Group increased their price objective on shares of Humana from $158.00 to $195.00 and gave the company a “sell” rating in a research note on Thursday, April 30th. Barclays raised their price objective on shares of Humana from $344.00 to $407.00 and gave the stock an “equal weight” rating in a report on Friday, July 31st. Truist Financial upped their target price on shares of Humana from $320.00 to $415.00 and gave the company a “hold” rating in a research note on Tuesday, July 14th. Finally, Raymond James Financial lowered shares of Humana from an “outperform” rating to a “market perform” rating in a research report on Thursday, July 30th. One analyst has rated the stock with a Strong Buy rating, fourteen have given a Buy rating, fourteen have given a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, Humana currently has a consensus rating of “Moderate Buy” and a consensus target price of $391.87.

Humana Profile

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.